Saturday Dec 19 | Medscape
FDA Approves First Generic Donepezil Orally Disintegrating Tablets for Dementia Related to AD
In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease
PRX-3140 - an orally-bioavailable Alzheimer's treatment - is in Phase 2 clinical studies.
Generic Aricept Approved for Alzheimer's Dementia
Generic versions of the drug Aricept that will dissolve instantly on the tongue have been approved by the U.S. Food and Drug Administration to treat dementia resulting from Alzheimer's disease, the agency said Tuesday.
FDA Approves First Generic Aricept to Treat Dementia Related to Alzheimer's Disease
The FDA approved the first generic versions of Aricept orally disintegrating tablet s on Dec.
Early Alzheimer's diagnosis 'is vital'
A RETIRED Church of Ireland Bishop has stressed the importance of an early diagnosis of Alzheimer's disease.
Lundbeck initiates clinical phase II trials with Lu AE58054 as...
The clinical phase II study is planned to enrol approximately 270 patients. The purpose of this study is to investigate if Lu AE58054 after 24 weeks improves cognition and functional outcomes in patients with moderate Alzheimer's disease that are already in treatment with donepezil.
Alzheimer's: love as effective as medicine
Love as effective as medicine for Alzheimer's? Researchers have found evidence that the physical and mental decline of Alzheimer's patients was slower for patients who have a close relationship with their caregivers.
Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In...
Main Category: Alzheimer's / Dementia Also Included In: Clinical Trials / Drug Trials Article Date: 04 Nov 2009 - 23:00 PST Pfizer Inc and Medivation, Inc.
Smart Pills: More Focus or Hocus Pocus?
Theya TMre all the buzz, and more of my patients seem to be asking for them: Drugs that can improve attention span and memory and help them be more productive at work.
EPIX Pharmaceuticals Announces FDA Approval Of A Physician-Sponsored...
Main Category: Alzheimer's / Dementia Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials The FDA has approved a Physician-Sponsored IND and continuation of the fourth 6-month open label extension of PRX-03140, a novel 5HT4 partial agonist for the potential treatment of Alzheimer's Disease.
Smartness In A Bottle: Nootropics Reach Concern Levels In Students
A Some estimates in competitive sports put athletic doping usage at 95%, for example, which sounds ridiculously high unless your slippery slope meter works overtime.
Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimer's
People taking one of several drugs commonly prescribed to treat Alzheimer's disease are more likely to be hospitalized for a potentially serious condition called bradycardia than patients not taking these medications.
Increase in 'academic doping' could spark routine urine tests for exam students
The increasing use of smart drugs or "nootropics," to boost academic performance, could mean that exam students will face routine doping tests in future, suggests an article in the Journal of Medical Ethics .
Eisai Announces Agreement with Pfizer on Strategic Alliance for...
Eisai Co., Ltd. announced that it has reached a comprehensive agreement with Pfizer Inc.
Aricept Opens Doors To Dreaming
Every medication can have side effects. That's a given. Whether or not you can live with the side effect is the big question.
Where can I get more informatin?. If you take viagra soft tabs, celecoixb for a long period of time, your doctor cymbalta withdrawal, may want to check you on a regular basis buy clonazepam without prescription, to make sure this medicaton is not causng harmul lawsuits for reglan, effecst.
SHRI enrolls Alzheimera s patients in clinical trial
Sun Health Research Institute is enrolling patients with Alzheimer's disease in the CONCERT study, a new clinical trial that will test an investigational drug.
Drugs to treat dementia wanted on NHF list
The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.
Drugs to treat dementia wanted on NHF list
The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.
Drugs to treat dementia wanted on NHF list
The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.
Also on Topix